GPR119 agonist (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GPR119 agonist (investigational), covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: GPR119 Agonist for Hypoglycemia in Type 1 Diabetes [Phase 2]